Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

PHENOBARBITAL

Form:

6 of 6 products shown

5 general benefit · 1 Limited Use

Other products in the same Health Canada class (N03A, N03AA) — coverage varies; not interchangeable

  • Primidone (Primidone): general benefit, Not a benefit
  • Carbamazepine (Tegretol): general benefit, Limited Use, Not a benefit, Listing status unconfirmed
  • Clonazepam (Rivotril): general benefit
  • Divalproex (Epival): general benefit
  • Ethosuximide (Zarontin): general benefit
  • Lamotrigine (Lamictal): general benefit

14 more in the class list below

Phenobarb Elixir · DIN 00645575 · 5mg/mL · Oral Elixir

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Phenobarb Elixir · DIN 00645575 Manufacturer: Pendopharm, Division of Pharmascience Inc.; listing date 2018-01-31 Health Canada: Marketed since 2012-03-05 · brand PHENOBARB ELIXIR · ATC N03AA02 PHENOBARBITAL, N03AA02 PHENOBARBITAL · form Solution · route Oral · ingredients PHENOBARBITAL 5 MG/ML · company Pendopharm division of pharmascience inc · schedule Controlled drugs (cdsa iv)
Check this DIN again · Health Canada product record

Phenobarb Elixir: Formulary list price $0.1535/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1535 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6095 · Verify on the e-Formulary ↗ (DIN 00645575)

Source record
DIN 00645575: Phenobarb Elixir Raw flags: sec3=Y Item: 282400235; group id 527; item number 1424; lccId None; manufacturer id PEN Source form: Oral Elixir; strength: 5mg/mL Recorded listing: General benefit Source prices (unrounded): $0.1535; ministry $0.1535 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00645575 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=6095
Shortage status: resolved shortage (ended 2024-12-10); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00645575
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Phenobarb · DIN 00178799 · 15mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Phenobarb · DIN 00178799 Manufacturer: Pendopharm, Division of Pharmascience Inc.; listing date 2018-01-31 Health Canada: Marketed since 2012-03-19 · brand PHENOBARB · ATC N03AA02 PHENOBARBITAL, N03AA02 PHENOBARBITAL · form Tablet · route Oral · ingredients PHENOBARBITAL 15 MG · company Pendopharm division of pharmascience inc · schedule Controlled drugs (cdsa iv)
Check this DIN again · Health Canada product record

Phenobarb: Formulary list price $0.0829/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0829 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=405 · Verify on the e-Formulary ↗ (DIN 00178799)

Source record
DIN 00178799: Phenobarb Raw flags: sec3=Y Item: 282400236; group id 527; item number 1425; lccId None; manufacturer id PEN Source form: Tab; strength: 15mg Recorded listing: General benefit Source prices (unrounded): $0.0829; ministry $0.0829 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00178799 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=405
Shortage status: resolved shortage (ended 2022-03-11); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00178799
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Phenobarb · DIN 00178802 · 30mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Phenobarb · DIN 00178802 Manufacturer: Pendopharm, Division of Pharmascience Inc.; listing date 2018-01-31 Health Canada: Marketed since 2012-03-05 · brand PHENOBARB · ATC N03AA02 PHENOBARBITAL, N03AA02 PHENOBARBITAL · form Tablet · route Oral · ingredients PHENOBARBITAL 30 MG · company Pendopharm division of pharmascience inc · schedule Controlled drugs (cdsa iv)
Check this DIN again · Health Canada product record

Phenobarb: Formulary list price $0.0987/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0987 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=406 · Verify on the e-Formulary ↗ (DIN 00178802)

Source record
DIN 00178802: Phenobarb Raw flags: sec3=Y Item: 282400237; group id 527; item number 1426; lccId None; manufacturer id PEN Source form: Tab; strength: 30mg Recorded listing: General benefit Source prices (unrounded): $0.0987; ministry $0.0987 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00178802 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=406
Shortage status: resolved shortage (ended 2019-03-08); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00178802
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Phenobarb · DIN 00178810 · 60mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Phenobarb · DIN 00178810 Manufacturer: Pendopharm, Division of Pharmascience Inc.; listing date 2018-01-31 Health Canada: Marketed since 2012-03-05 · brand PHENOBARB · ATC N03AA02 PHENOBARBITAL, N03AA02 PHENOBARBITAL · form Tablet · route Oral · ingredients PHENOBARBITAL 60 MG · company Pendopharm division of pharmascience inc · schedule Controlled drugs (cdsa iv)
Check this DIN again · Health Canada product record

Phenobarb: Formulary list price $0.1338/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1338 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=407 · Verify on the e-Formulary ↗ (DIN 00178810)

Source record
DIN 00178810: Phenobarb Raw flags: sec3=Y Item: 282400238; group id 527; item number 1427; lccId None; manufacturer id PEN Source form: Tab; strength: 60mg Recorded listing: General benefit Source prices (unrounded): $0.1338; ministry $0.1338 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00178810 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=407
Shortage status: resolved shortage (ended 2024-07-26); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00178810
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Phenobarb · DIN 00178829 · 100mg · tablet

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
Phenobarb · DIN 00178829 Manufacturer: Pendopharm, Division of Pharmascience Inc.; listing date 2018-01-31 Health Canada: Marketed since 2012-03-05 · brand PHENOBARB · ATC N03AA02 PHENOBARBITAL, N03AA02 PHENOBARBITAL · form Tablet · route Oral · ingredients PHENOBARBITAL 100 MG · company Pendopharm division of pharmascience inc · schedule Controlled drugs (cdsa iv)
Check this DIN again · Health Canada product record

Phenobarb: Formulary list price $0.1831/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1831 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=408 · Verify on the e-Formulary ↗ (DIN 00178829)

Source record
DIN 00178829: Phenobarb Raw flags: sec3=Y Item: 282400174; group id 527; item number 1428; lccId None; manufacturer id PEN Source form: Tab; strength: 100mg Recorded listing: General benefit Source prices (unrounded): $0.1831; ministry $0.1831 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00178829 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=408
Shortage status: resolved shortage (ended 2018-10-29); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00178829
Shortage record checked 2026-09-13T08:10:21.292534+00:00

Phenobarbital Injection · DIN 02304090 · 120mg/mL · injection solution-1mL Pk

Limited Use — Reason for Use code 481 requiredMarketed · checked 2026-09-02
StatusLimited Use — Reason for Use code 481 required
Write on scriptLU code 481 (patient must meet the criteria below)
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
Ontario Limited Use criteria — code 481
Reason for Use code 481 For the management of patients receiving palliative care*. Coverage limit: LU Authorization Period: 1 year Coverage limit: *The patient must have a progressive life-limiting illness and require this medication for palliative purposes.
No interchangeable product listed in the Ontario extract
Phenobarbital Injection · DIN 02304090 Manufacturer: Sandoz Canada Inc.; listing date 2018-01-31 Health Canada: Marketed since 2008-02-29 · brand PHENOBARBITAL SODIUM INJECTION, USP · ATC N03AA02 PHENOBARBITAL, N03AA02 PHENOBARBITAL · form Solution · route Intramuscular, Intravenous · ingredients PHENOBARBITAL SODIUM 120 MG/ML · company Sandoz canada incorporated · schedule Controlled drugs (cdsa iv)
Check this DIN again · Health Canada product record

Phenobarbital Injection: Formulary list price $15.7000/unit (unit not stated in source; not the patient's cost)

Ministry pays: $15.7000 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=78940 · Verify on the e-Formulary ↗ (DIN 02304090)

Source record
DIN 02304090: Phenobarbital Injection Raw flags: sec12=Y, sec3=Y Item: 281200073; group id 438; item number 1096; lccId 00294; manufacturer id SDZ Source form: Inj Sol-1mL Pk; strength: 120mg/mL Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below Source prices (unrounded): $15.7000; ministry $15.7000 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02304090 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=78940
Shortage status: resolved shortage (ended 2024-06-12); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02304090
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary classes and how they are covered

Other drugs in the same formulary class (28:12 Anticonvulsants) and how they are covered

Matched class: 28:12 Anticonvulsants

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: CLONAZEPAM, DIVALPROEX SODIUM, ETHOSUXIMIDE, LAMOTRIGINE, VALPROATE SODIUM Some products covered without a code (check the product listing): CARBAMAZEPINE, GABAPENTIN, PHENYTOIN (DIPHENYLHYDANTOIN), PHENYTOIN (DIPHENYLHYDANTOIN) SODIUM, PREGABALIN, PRIMIDONE, TOPIRAMATE, VALPROIC ACID 28:12 Anticonvulsants

PRIMIDONE

· 4 products · General benefit (2), Listed, not a benefit (2) · strengths: 125mg, 250mg · Tab

CARBAMAZEPINE

· 15 products · Listed, not a benefit (3), General benefit (6), Temporary benefit (2), Limited Use, codes 67 (4) · strengths: 100mg, 200mg, 400mg, 100mg/5mL · Chew Tab, ER Tab, LA Tab, Oral Susp, Tab

CLONAZEPAM

· 9 products · General benefit · strengths: 0.5mg, 2mg · Tab

DIVALPROEX SODIUM

· 9 products · General benefit · strengths: 125mg, 250mg, 500mg · Ent Tab

ETHOSUXIMIDE

· 4 products · General benefit · strengths: 250mg, 50mg/mL · Cap, O/L

LAMOTRIGINE

· 28 products · General benefit · strengths: 25mg, 100mg, 150mg · Tab

PHENYTOIN (DIPHENYLHYDANTOIN)

· 4 products · General benefit; DIN status E (meaning unconfirmed); confirm discontinuation/availability with Health Canada (2), General benefit (2) · strengths: 6mg/mL, 25mg/mL, 50mg · O/L, Tab

PHENYTOIN (DIPHENYLHYDANTOIN) SODIUM

· 4 products · General benefit (3), Limited Use, codes 481, 657 (1) · strengths: 30mg, 100mg, 50mg/mL · Cap, Inj Sol (Preservative Free)

TOPIRAMATE

· 54 products · Limited Use, codes 321 (2), Off-Formulary Interchangeable, not an ODB benefit (3), General benefit (49) · strengths: 15mg, 25mg, 50mg, 100mg, 200mg · Sprinkle Cap, Tab

VALPROATE SODIUM

· 5 products · General benefit · strengths: 50mg/mL · O/L

VALPROIC ACID

· 5 products · Listed, not a benefit (2), General benefit (3) · strengths: 250mg, 500mg · Cap, Ent Cap

BRIVARACETAM

· 12 products · Limited Use, codes 548 · strengths: 10mg, 25mg, 50mg, 75mg, 100mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 28:12 and 11 more
Full class listing Related classes: 28:08 Analgesics, 28:10 Opiate Antagonists, 28:16 Psychotherapeutic Agents, 28:20 C.N.S. Stimulants, 28:24 Sedatives and Hypnotics, 28:36 Antiparkinsonian Agents, 28:92 Miscellaneous Central Nervous System Drugs

Other drugs in the same formulary class (28:24 Sedatives and Hypnotics) and how they are covered

Matched class: 28:24 Sedatives and Hypnotics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: NITRAZEPAM, TEMAZEPAM Some products covered without a code (check the product listing): BUSPIRONE HYDROCHLORIDE, FLURAZEPAM, METHOTRIMEPRAZINE, TRIAZOLAM 28:24 Sedatives and Hypnotics

BUSPIRONE HYDROCHLORIDE

· 9 products · Listed, not a benefit (1), General benefit (8) · strengths: 10mg · Tab

FLURAZEPAM

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 15mg, 30mg · Cap

METHOTRIMEPRAZINE

· 9 products · General benefit (5), Listed, not a benefit (4) · strengths: 25mg/mL, 2mg, 5mg, 25mg, 50mg · Inj Sol-1mL Pk, Tab

NITRAZEPAM

· 2 products · General benefit · strengths: 5mg, 10mg · Tab

TEMAZEPAM

· 2 products · General benefit · strengths: 15mg, 30mg · Cap

TRIAZOLAM

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 0.125mg, 0.25mg · Tab

LORAZEPAM

· 9 products · Listed, not a benefit (1), Limited Use, codes 481 (2), Off-Formulary Interchangeable, not an ODB benefit (6) · strengths: 4mg/mL, 0.5mg, 1mg, 2mg · Inj Sol (with preservative), SL Tab

MIDAZOLAM

· 3 products · Listed, not a benefit (1), Limited Use, codes 495, 496 (2) · strengths: 5mg/mL · Inj Sol (with Preservative)

ESZOPICLONE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1mg, 2mg, 3mg · Tab

ZOLPIDEM TARTRATE

· 10 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 5mg, 10mg · SL Tab

ZOPICLONE

· 40 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 3.75mg, 5mg, 7.5mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 28:24
Full class listing Related classes: 28:08 Analgesics, 28:10 Opiate Antagonists, 28:12 Anticonvulsants, 28:16 Psychotherapeutic Agents, 28:20 C.N.S. Stimulants, 28:36 Antiparkinsonian Agents, 28:92 Miscellaneous Central Nervous System Drugs Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS As a sedative, for the relief of anxiety, tension and apprehension. As a hypnotic, for the short-term management of insomnia. As an anticonvulsant, for the long-term treatment of generalized tonicoclonic and partial (cortical focal) seizures. As prophylaxis and treatment of febrile seizures. As an antihyperbilirubinemic, for the prevention and treatment of hyperbilirubinemia in neonates, also to lower bilirubin concentrations in patients with congenital non-hemolytic unconjugated hyperbilirubinemia or chronic intrahepatic cholestasis. https://pdf.hres.ca/dpd_pm/00085981.PDF PM date: SEP 04, 2026 Source product: PMS-PHENOBARBITAL; DIN 00178799; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.